These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 6912276)

  • 1. Human monocyte spreading induced by factor Bb of the alternative pathway of complement activation. A possible role for C5 in monocyte spreading.
    Sundsmo JS; Götze O
    J Exp Med; 1981 Sep; 154(3):763-77. PubMed ID: 6912276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human monocyte spreading induced by activated factor B of the complement alternative pathway: differential effects of Fab' and F(ab')2 antibody fragments directed to C5, C6, and C7.
    Sundsmo JS; Götze O
    Cell Immunol; 1983 Apr; 77(1):176-86. PubMed ID: 6601526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated factor B (Bb) of the alternative pathway of complement activation cleaves and activates plasminogen.
    Sundsmo JS; Wood LM
    J Immunol; 1981 Sep; 127(3):877-80. PubMed ID: 6911148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of the intracellular killing of Staphylococcus aureus by monocytes: regulation by immunoglobulin G and complement components C3/C3b and B/Bb.
    Leijh PC; van den Barselaar MT; Daha MR; van Furth R
    J Immunol; 1982 Jul; 129(1):332-7. PubMed ID: 6979568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The induction of macrophage spreading by factor B of the properdin system.
    Götze O; Bianco C; Cohn ZA
    J Exp Med; 1979 Feb; 149(2):372-86. PubMed ID: 570212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of induction of IL-1 production in human monocytes by complement fragments.
    Arend WP; Massoni RJ; Niemann MA; Giclas PC
    J Immunol; 1989 Jan; 142(1):173-8. PubMed ID: 2783323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of macrophage migration by products of the complement system.
    Bianco C; Götze O; Cohn ZA
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):888-91. PubMed ID: 284412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monocyte spreading induced by factor B of the alternative pathway of complement activation.
    Sundsmo JS; Götze O
    Cell Immunol; 1980 Jun; 52(1):1-17. PubMed ID: 6901508
    [No Abstract]   [Full Text] [Related]  

  • 9. Leukocyte complement: a possible role for C5 in lymphocyte stimulation.
    Sundsmo JS
    J Immunol; 1983 Aug; 131(2):886-91. PubMed ID: 6223096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte complement: interleukin-like properties of factor Bb.
    Hirani S; Fair DS; Papin RA; Sundsmo JS
    Cell Immunol; 1985 May; 92(2):235-46. PubMed ID: 3846490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT; Schreiber RD; Cooper NR
    J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alternative pathway C3/C5 convertase: chemical basis of factor B activation.
    Lesavre PH; Hugli TE; Esser AF; Müller-Eberhard HJ
    J Immunol; 1979 Aug; 123(2):529-34. PubMed ID: 458145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
    Fishelson Z; Müller-Eberhard HJ
    J Immunol; 1984 Mar; 132(3):1425-9. PubMed ID: 6229580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement.
    Farries TC; Lachmann PJ; Harrison RA
    Biochem J; 1988 Aug; 253(3):667-75. PubMed ID: 3140783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ba and Bb fragments of factor B activation: fragment production, biological activities, neoepitope expression and quantitation in clinical samples.
    Kolb WP; Morrow PR; Tamerius JD
    Complement Inflamm; 1989; 6(3):175-204. PubMed ID: 2472921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanosoma lewisi: restriction of alternative complement pathway C3/C5 convertase activity.
    Sturtevant JE; Balber AE
    Exp Parasitol; 1987 Jun; 63(3):260-71. PubMed ID: 3556206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the binding molecules for factor B and its fragment, Bb, of human complement on human monocytes after in vitro cultivation.
    Saeki T; Nagasawa S
    Immunol Lett; 1989 Jan; 20(2):97-101. PubMed ID: 2654014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cycloheximide and of anti-C3 Fab' on the intrinsic synthesis and secretion of lysosomal enzyme and of complement components by guinea-pig peritoneal macrophages.
    Kreuzpaintner G; Brade V
    Immunology; 1983 Jun; 49(2):337-42. PubMed ID: 6552217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative complement pathway activation fragment Ba binds to C3b. Evidence that formation of the factor B-C3b complex involves two discrete points of contact.
    Pryzdial EL; Isenman DE
    J Biol Chem; 1987 Feb; 262(4):1519-25. PubMed ID: 3643213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of a 33,000-dalton fragment of complement Factor B with catalytic and C3b binding activity.
    Lambris JD; Müller-Eberhard HJ
    J Biol Chem; 1984 Oct; 259(20):12685-90. PubMed ID: 6567645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.